Examine the Epidemiology and Outcomes of Transitions From PD-to-HD in Canada
NCT07477210
Hemodialysis, Kidney Replacement Therapy
Montreal, Quebec, Canada
View Trial DetailsNCT Number: NCT07437677
Home dialysis is encouraged in Canada and peritoneal dialysis is the most common home dialysis method. However, many patients discontinue peritoneal dialysis, often transferring to hemodialysis. Despite the frequency of this transition, little is known about its impact on patients.
Overall, the UPLIFT-PD program aims to fill this gap by studying the transition from peritoneal dialysis to hemodialysis. The specific goal of this mixed methods sub-study is to conduct a national survey to ask patients and caregivers about priorities and preferences when they anticipate a transfer from peritoneal dialysis to hemodialysis. This survey will be co-created by patient-partners and dialysis experts.
Results from this survey will then be used in other phases of UPLIFT-PD program, detailed in other registrations, which will support people facing a transition from peritoneal dialysis to hemodialysis..
Trial opening soon.
Get Notified18 year and older
All sexes
Observational
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: At survey completion (Baseline)
Measured using Likert-scale responses assessing perceived importance of transition-related factors (e.g. preparedness, timing of discussions, vascular access planning, psychosocial impact). Likert-scale from 0 (lowest importance) to 9 (highest importance)
Time frame: At survey completion (Baseline)
Assessed using a discrete choice experiment evaluating trade-offs between attributes such as duration on PD, risk of complications, and planned vs. unplanned HD transfer.
Time frame: At survey completion (Baseline)
Agreement with proposed definitions of successful PD-to-HD transitions based on care pathways.
Time frame: At survey completion (Baseline)
Analysis of open-ended responses to identity key themes and concepts.
Contact information is provided by the study sponsor or research team.
Annie-Claire Nadeau-Fredette, MD MSc
CONTACT
514-252-3400 ext. 6141
Émilie Robitaille
CONTACT
514-252-3400 ext. 5289
Ciusss de L'Est de l'Île de Montréal
Other
Understand, Plan and Improve Care and Wellbeing of Patients at High Risk of Transfer From Peritoneal Dialysis to Hemodialysis - Phase 2 (Survey)
Acronym: ULIFT-PD
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07477210
Hemodialysis, Kidney Replacement Therapy
Montreal, Quebec, Canada
View Trial DetailsNCT07686978
Chronic Disease, Disease Attributes
Ankara, Turkey (Türkiye)
View Trial DetailsNCT06830941
Peritoneal Dialysis (PD), Renal Anemia
View Trial DetailsNCT07724327
Large Language Models, Peritoneal Dialysis (PD)
Guangzhou, Guangdong, China
View Trial Details